Search research articles
Contact Us
Filters
Showing results (131-140 of 1,010) with videos related to
Page
of 101
Sort By:
Handbook of Experimental Pharmacology
|
April 14, 2006
Proarrhythmia
D M Roden, M E Anderson
Clinical Pharmacology and Therapeutics
|
July 23, 2013
Genomic medicine, precision medicine, personalized medicine: what's in a name?
D M Roden, R F Tyndale
Circulation
|
March 23, 2013
Stem cell-derived cardiomyocytes as a tool for studying proarrhythmia: a better canary in the coal mine?
Dan M Roden, Charles C Hong
Heart (British Cardiac Society)
|
August 24, 2000
The pause that refreshes, or does it? Mechanisms in torsades de pointes
D M Roden, M E Anderson
Cardiovascular Research
|
February 26, 2000
A plethora of mechanisms in the HERG-related long QT syndrome. Genetics meets electrophysiology
D M Roden, J R Balser
Journal of Cardiovascular Electrophysiology
|
March 25, 1999
Drug-induced J point elevation: a marker for genetic risk of sudden death or ECG curiosity?
D M Roden, A A Wilde
Nature Reviews. Drug Discovery
|
July 18, 2002
The genetic basis of variability in drug responses
Dan M Roden, Alfred L George
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
June 1, 1991
Effect of glucocorticoid substitution on the secretion of atrial natriuretic peptide (ANP) in patients with adrenocortical insufficiency
M Roden, P Damjancic, H Vierhapper
Heart Rhythm
|
June 29, 2011
Refining repolarization reserve
Dan M Roden, Robert L Abraham
Diabetic Medicine : a Journal of the British Diabetic Association
|
June 11, 2011
Neuropad: evaluation of three cut-off points of sudomotor dysfunction for early detection of polyneuropathy in recently diagnosed diabetes
D Ziegler, N Papanas, M Roden, et al.
Page
of 101
Search research articles
Search
Showing results (131-140 of 1,010) with videos related to
Sort By:
Page
of 101
Handbook of Experimental Pharmacology
|
April 14, 2006
Proarrhythmia
D M Roden, M E Anderson
Clinical Pharmacology and Therapeutics
|
July 23, 2013
Genomic medicine, precision medicine, personalized medicine: what's in a name?
D M Roden, R F Tyndale
Circulation
|
March 23, 2013
Stem cell-derived cardiomyocytes as a tool for studying proarrhythmia: a better canary in the coal mine?
Dan M Roden, Charles C Hong
Heart (British Cardiac Society)
|
August 24, 2000
The pause that refreshes, or does it? Mechanisms in torsades de pointes
D M Roden, M E Anderson
Cardiovascular Research
|
February 26, 2000
A plethora of mechanisms in the HERG-related long QT syndrome. Genetics meets electrophysiology
D M Roden, J R Balser
Journal of Cardiovascular Electrophysiology
|
March 25, 1999
Drug-induced J point elevation: a marker for genetic risk of sudden death or ECG curiosity?
D M Roden, A A Wilde
Nature Reviews. Drug Discovery
|
July 18, 2002
The genetic basis of variability in drug responses
Dan M Roden, Alfred L George
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
June 1, 1991
Effect of glucocorticoid substitution on the secretion of atrial natriuretic peptide (ANP) in patients with adrenocortical insufficiency
M Roden, P Damjancic, H Vierhapper
Heart Rhythm
|
June 29, 2011
Refining repolarization reserve
Dan M Roden, Robert L Abraham
Diabetic Medicine : a Journal of the British Diabetic Association
|
June 11, 2011
Neuropad: evaluation of three cut-off points of sudomotor dysfunction for early detection of polyneuropathy in recently diagnosed diabetes
D Ziegler, N Papanas, M Roden, et al.
Page
of 101